EAHAD 2026
Octapharma Symposium
:quality(80))
Tailored to the Patient, Driven by Data: Optimising Prophylaxis in VWD
Wednesday, 4 February, 2026
17:30- 18:30 GMT
Room: Liffey A
Convention Centre Dublin (CCD)
Despite advances, patients with von Willebrand disease still face significant treatment gaps. In this interactive symposium, leading experts will share new insights from clinical studies and real-world practice, showing the impact of data-driven and PopPK-guided approaches on prophylaxis. Join us to explore the future of truly personalised VWD care.
Meet the speakers
Welcome and Introduction
Still bleeding, Still Waiting: Understanding the Gaps in VWD Management
Michelle Lavin, IE
Bringing Personalised Prophylaxis into Practice: Real-World Perspectives and Patient Impact
Robert F. Sidonio Jr., US
Leveraging Population PK Models Towards Individualized Dosing in VWD
Ron Mathot, NL
This symposium is for healthcare professionals attending the EAHAD congress only and is organised and sponsored by Octapharma. It has been approved in line with Irish regulations for an international audience. Prescribing information may vary depending on local approval in each country. Before prescribing any product, always refer to local materials such as the prescribing information and/or the summary of product characteristics. This is a promotional symposium and products will be discussed.
:quality(80))
Can't attend the meeting?
Visit One Source, Octapharma’s online heamatology platform for healthcare professionals to access the materials on-demand.
:quality(80))